CA 19-9 to differentiate benign and malignant masses in chronic pancreatitis: is there any benefit?

CEA, CA 19-9, and CA 125 in the differen

CEA, CA 19-9, and CA 125 in the differential diagnosis of benign and malignant pancreatic diseases with or without jaundice

✍ Nüvit Duraker; Semih Hot; Yücel Polat; Anil Höbek; Nur Gençler; Nuray Urhan 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

## Abstract ## Background and Objectives In this study, the value of the serum tumor markers carcinoembryonic antigen (CEA), CA 19‐9, and CA 125 was assessed in the differential diagnosis of benign and malignant pancreatic diseases with and without obstructive jaundice. ## Methods Serum levels o